Valued at USD 14.85 billion in 2022, the mineral supplements market is projected to reach USD 15.40 billion in 2023 and USD 20.85 billion by 2032, growing at a CAGR of 3.4% during the forecast period 2023–2032. According to Polaris Market Research, growth is supported by rising health and wellness awareness, with chronic conditions such as cancer, osteoporosis and anemia driving supplement use.

For nutraceutical manufacturers, pharmacies and ingredient suppliers, the Mineral Supplements Market is segmented by product, formulation, application, sales channel and end use. Products covered include calcium, magnesium, iron, potassium, zinc, chromium and selenium.

Calcium Supplements Lead the Product Segment

Calcium supplements led by product in 2022, driven by the rising prevalence of osteoporosis, especially among women and older adults. The report cites about 8.9 million osteoporosis-related fractures per year, according to the International Osteoporosis Foundation, and notes that about 2 million Canadians were diagnosed with the condition in 2017. New product introductions also contributed. Campaigns reinforce awareness: iNova Pharmaceuticals ran its "Big O" osteoporosis and calcium campaign in 2018, and Torrent Pharmaceuticals launched the #BeShelcalStrong campaign on calcium deficiency in February 2023.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/mineral-supplements-market

Potassium Is Expected to Grow Fastest

Potassium is expected to be the fastest-growing product. Cited benefits include fluid balance, nerve impulse transmission and smooth muscle contraction, and potassium is linked to reduced water retention, lower blood pressure, lower stroke and cardiovascular risk, and prevention of kidney stones and osteoporosis. Companies are developing potassium ingredients suited to various formats.

Bone and Joint Health Is the Largest Application

Bone and joint health led the application mix in 2022, driven by calcium deficiencies among teenagers and women and by aging populations susceptible to osteoporosis and arthritis. Iron deficiency is reported as the most common deficiency in the United States, underlining the breadth of nutritional gaps that supplements address.

Tablets and Adults Dominate Format and End Use

Tablets held the largest share by form, owing to wide availability, convenience and high consumer acceptance. Adults led by end use, reflecting mineral deficiencies, particularly among working women at higher risk of calcium deficiency, as well as consumers following vegan or gluten-free diets. Capsules, powders and liquid or gel products complete the formulation list.

Awareness Campaigns, Research and End-Use Groups

Pharmaceutical awareness campaigns and rising lifestyle diseases are cited as drivers. Research referenced in the report suggests that higher-than-recommended mineral doses may reduce viral load and hospitalization in COVID-19 patients, and iNova's B-Cal calcium line gained traction in South Africa. Geriatric consumers, pregnant women and infants are listed among the end-use groups alongside adults and children. Country coverage includes the U.S. and Canada in North America; France, Germany, the UK, Italy, the Netherlands, Spain and Russia in Europe; Japan, China, India, Malaysia, Indonesia and South Korea in Asia Pacific; Brazil, Mexico and Argentina in Latin America; and Saudi Arabia, the UAE, Israel and South Africa in the Middle East & Africa.

Regional Outlook for the Mineral Supplements Market

Asia Pacific was the largest region in 2022, supported by a growing older population, many market players and rising disposable income. The Middle East is expected to post a robust CAGR, driven by more regional manufacturers and awareness campaigns. North America, Europe and Latin America are also covered, though regulatory challenges are listed as a restraint.

Competitive Landscape and Key Players

Key players  Mineral Supplements   include Abbott, Amway, Bayer, Bio Botanica, Biovea, DSM, Glanbia, Herbalife International, Nestle, Nu Skin, Omega Protein, Pharmavite and Sanofi. Polaris rates rivalry among existing firms as high, the threat of new entrants as low, and supplier power, buyer power and substitutes as moderate.

More Trending Latest Reports By Polaris Market Research:

corn-market

variable-frequency-drive-market

industrial-mixers-market

legal-services-market

cryptocurrency-market

https://www.polarismarketresearch.com/press-releases/it-services-market

dermatology-drugs-market

landscaping-services-market

synthetic-data-generation-market